Lawrence J. Green, M.D., from George Washington University in Washington, D.C., and colleagues randomized (2:1) 430 patients to receive halobetasol propionate Lotion or vehicle once daily for eight weeks, with assessments at two, four, six, and eight weeks of treatment as well as at a four-week post-treatment follow-up visit. (HealthDay)—Halobetasol propionate 0.01 percent lotion (BRYHALI Lotion) appears safe and effective...